Telesta Therapeutics (Formerly known as Bioniche Life Sciences)
275 Labrosse Avenue
Pointe-Claire
Quebec
H9R 1A3
Canada
Tel: 514-697-6636
Fax: 613-966-9485
Website: http://www.telestatherapeutics.com/
Email: info@telestatherapeutics.com
203 articles about Telesta Therapeutics (Formerly known as Bioniche Life Sciences)
-
Telesta Announces Final Court Approval Of Plan Of Arrangement With ProMetic Life Sci
10/31/2016
-
Telesta Announces Closing Of Arrangement With ProMetic Life Sci
10/31/2016
-
Telesta Shareholders Approve Plan Of Arrangement With ProMetic Life Sci
10/25/2016
-
Leading Independent Advisory Firms ISS And Glass Lewis Recommend Shareholders Vote FOR The Plan Of Arrangement Between Telesta And ProMetic Life Sci
10/12/2016
-
Telesta Publishes Its Annual Financial Statements And Provides Date Of Special Shareholders Meeting
9/19/2016
-
ProMetic Life Sci Takes Out Telesta in All Share Transaction
8/24/2016
-
Struggling Telesta Cuts Another 30% of Workforce, Will Shutter Montreal Facility
8/2/2016
-
Telesta Publishes Its Q3, 2016 Financial Statements And Provides Corporate Updates
5/10/2016
-
After FDA Type A Meeting, Telesta Eyes Major Restructuring and a Partner to Continue Phase III Trial
4/18/2016
-
Telesta Corporate Update - Type A Meeting With The FDA Scheduled
4/13/2016
-
Telesta Requests Meeting With FDA Over Bladder Cancer Drug, Slashes Jobs by 15%
3/9/2016
-
Telesta Publishes Its Q2, 2016 Financial Statements And Provides Corporate Updates
2/12/2016
-
Telesta Receives Complete Response Letter From FDA
2/2/2016
-
Telesta Corporate Update
12/14/2015
-
FDA Panel Rejects Telesta's Bladder Cancer Drug MCNA
11/19/2015
-
Telesta Announces Results Of Annual General Meeting Of Shareholders
11/16/2015
-
Telesta Publishes Its Q1, 2016 Financial Statements And Provides Corporate Updates
11/12/2015
-
Telesta, Ipsen Strike $137 Million+ Bladder Cancer Pact
10/28/2015
-
Telesta Appoints Brian J. Groch As Chief Commercial Officer
10/8/2015
-
Telesta Announces FDA Advisory Committee Date For MCNA1
9/28/2015